“Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease”. Journal of Pharmaceutical Negative Results (January 1, 2022): 2532–2541. Accessed June 8, 2026. https://pnrjournal.com/index.php/home/article/view/9456.